Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Midcap Index at life time high
Thu, 16 Jul 01:30 pm

The benchmark indices have remained firm due to the strength in index heavyweights such as Axis Bank, HDFC and Reliance Industries (RIL).

The BSE-Sensex is trading up by 153 points (0.54%) and the NSE-Nifty is trading up by 51 points (0.59%). The S&P BSE Midcap index is trading up by 110 points (1%), while the S&P BSE Smallcap index is trading up by 77 points (0.66%). The rupee is trading at 63.49 to the US dollar. Gold and Silver are trading at Rs 25,778 per 10 grams & Rs 34,607 per kilogram respectively.

Stocks in Pharmaceutical sector are trading on a positive note with Panacea Biotech and Elder Pharma leading the winners. Biocon has set the price band for an initial public offering (IPO) of its clinical research service arm, Syngene International at Rs 240-250 a share. SEBI has approved its Red Herring Prospectus on July 15. It is expecting to raise around Rs 5,500 m to fund new research and development. The IPO will be open for subscription on July 27 and close on July 29. Silver Leaf Oak which owns 10% stake in the company would exit. Biocon is trading down by 0.54%.

Stocks in Banking sector are trading on a positive note with IDBI Bank and AXIS Bank leading the winners. foreign institutional investors (FIIs) have cut their exposure in public sector banks. They have reduced their exposure owing to concerns prevailing over worsening of the asset quality. The banks which have witnessed a reduction in FII stakes are Punjab National Bank (PNB), Oriental Bank of Commerce (OBC), Bank of Baroda (BOB), Bank of India (BOI) and Canara Bank. The foreign investors cut their stake up to 3 percentage points in the June quarter. A total of 28 banks both from the public and private sector have so far disclosed their June quarter shareholding, out of these FII's stake has declined in 21 banks. The asset quality challenges continue and with the attractiveness of restructuring waning, the stress might manifest in Non -Performing Assets (NPA).

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Midcap Index at life time high". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.